Ken Fisher Fisher Asset Management
Ken Fisher is the founder and executive chairman of Fisher Investments, a global money management firm overseeing billions of dollars in assets. He gained early recognition for pioneering the use of the price-to-sales ratio in stock analysis and wrote the long-running “Portfolio Strategy” column in Forbes. Over the years, Fisher has authored numerous books on investing and wealth management, many of which have become bestsellers.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Intermediate-Term Corporate Bond ETF
VCIT
|
+$274M |
| 2 |
FRLG
Large Cap Growth Index-Linked Exchange Traded Notes due 2028
FRLG
|
+$138M |
| 3 |
FIHD
UBS AG FI Enhanced Global High Yield ETN
FIHD
|
+$69.1M |
| 4 |
Lumentum
LITE
|
+$41.9M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$41.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
TSMC
TSM
|
+$171M |
| 2 |
Petrobras
PBR
|
+$64.7M |
| 3 |
Vale
VALE
|
+$62.7M |
| 4 |
WMGI
Wright Medical Group Inc
WMGI
|
+$61.9M |
| 5 |
HDFC Bank
HDB
|
+$57.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.83% |
| 2 | Financials | 13.08% |
| 3 | Healthcare | 10.74% |
| 4 | Consumer Discretionary | 8.75% |
| 5 | Energy | 5.83% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
AbbVie
ABBV
$443B
| $26.5M | 0.03% |
299,736
-120,362
| -29% | -$9.99M |
|
|
XYZ
227
Block Inc
XYZ
$48.4B
| $26.3M | 0.03% |
420,134
-103
| -0% | -$6.58K |
|
228
Ziff Davis
ZD
$1.96B
| $26.2M | 0.03% |
321,397
+6,450
| +2% | +$533K |
|
229
Omnicell
OMCL
$1.61B
| $25.9M | 0.03% |
317,043
-99,312
| -24% | -$7.62M |
|
|
CBD
230
DELISTED
Companhia Brasileira de Distribuicao
CBD
| $25.2M | 0.03% |
1,150,967
-7,154
| -0.6% | -$143K |
|
231
ATI
ATI
$25.6B
| $24.5M | 0.02% |
1,183,712
-47,415
| -4% | -$1.03M |
|
232
Prosperity Bancshares
PB
$8.97B
| $24.3M | 0.02% |
337,813
-13,475
| -4% | -$952K |
|
233
ProPetro Holding
PUMP
$1.36B
| $24M | 0.02% |
2,133,057
-257,818
| -11% | -$2.3M |
|
234
Abbott
ABT
$183B
| $23.8M | 0.02% |
274,305
-125,020
| -31% | -$10.5M |
|
235
Teradyne
TER
$57.6B
| $23.4M | 0.02% |
342,614
-163,675
| -32% | -$10.4M |
|
|
NEX
236
DELISTED
NexTier Oilfield Solutions Inc.
NEX
| $22.9M | 0.02% |
3,413,415
+842,417
| +33% | +$4.54M |
|
|
WDR
237
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $22.8M | 0.02% |
1,361,516
-382,191
| -22% | -$6.23M |
|
238
HubSpot
HUBS
$12.2B
| $22.5M | 0.02% |
142,159
+29,026
| +26% | +$4.44M |
|
239
iShares Core US Aggregate Bond ETF
AGG
$137B
| $22.5M | 0.02% |
200,091
+18,866
| +10% | +$2.13M |
|
240
EOG Resources
EOG
$79.2B
| $22.3M | 0.02% |
266,357
-21
| -0% | -$1.54K |
|
241
iShares 1-3 Year Treasury Bond ETF
SHY
$25.5B
| $22.2M | 0.02% |
261,898
+7,897
| +3% | +$669K |
|
242
Haemonetics
HAE
$3.89B
| $21.7M | 0.02% |
188,971
-48,817
| -21% | -$5.91M |
|
243
Viavi Solutions
VIAV
$9.12B
| $21.6M | 0.02% |
1,437,486
+322,406
| +29% | +$4.83M |
|
244
Knowles
KN
$3.13B
| $21.5M | 0.02% |
1,014,820
+666,360
| +191% | +$14.3M |
|
245
Rockwell Automation
ROK
$53.4B
| $21.1M | 0.02% |
104,034
-93,529
| -47% | -$17.3M |
|
246
Halozyme
HALO
$9.79B
| $21M | 0.02% |
1,182,663
+12,747
| +1% | +$221K |
|
247
PepsiCo
PEP
$190B
| $20.1M | 0.02% |
147,111
-43,387
| -23% | -$5.9M |
|
248
Diodes
DIOD
$3.78B
| $19.9M | 0.02% |
353,043
+43
| +0% | +$1.99K |
|
249
UMB Financial
UMBF
$11.1B
| $19.8M | 0.02% |
288,166
-38,630
| -12% | -$2.56M |
|
|
PXD
250
DELISTED
Pioneer Natural Resource Co.
PXD
| $19.8M | 0.02% |
130,476
-63,492
| -33% | -$8.45M |
|
Similar funds
Ken Fisher's Q4 2019 Portfolio in Review
As of Q4 2019, Ken Fisher held 981 positions worth $99B, up 8.6% from $91.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Ken Fisher's Q4 2019 filing shows 78 new, 256 increased, 457 reduced and 83 closed positions. Its largest new stake was Enterprise Products Partners: 584,777 shares worth $16.5M. The largest sale was TSMC, an estimated $171M.
By sector, the portfolio is most concentrated in Technology at 21% of assets, up from 20% a quarter earlier, followed by Financials and Healthcare.
- Ken Fisher's largest Q4 2019 buy was Enterprise Products Partners: 584,777 shares worth $16.5M.
- Ken Fisher added most to Vanguard Intermediate-Term Corporate Bond ETF in Q4 2019, an estimated $274M increase.
- Ken Fisher's biggest Q4 2019 reduction was TSMC, cutting an estimated $171M.
- Ken Fisher fully exited Wright Medical Group Inc in Q4 2019, selling an estimated $61.9M.
- Ken Fisher's ten largest holdings make up 28% of its $99B portfolio in Q4 2019.
- Ken Fisher opened 78 new positions and closed 83 in Q4 2019.
- Ken Fisher's portfolio value rose 8.6% quarter-over-quarter to $99B.
Based on Fisher Asset Management's 13F filing for Q4 2019, filed 12 Feb 2020.